Streetbeat News

Stock Prices

BAC

Wealthy investors are showing a bullish stance on Bank of America (NYSE:BAC) with significant options trades. Benzinga's options scanner detected 17 unusual trades, with 64% being bullish. The projected price target for BAC is between $37.0 and $50.0. The stock is currently down 0.92% at $40.49, with a recent analyst upgrade from Deutsche Bank to a Buy rating and a target price of $45.0.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:01 pm

CWH

Analysts have varied opinions on Camping World Holdings (NYSE:CWH), with recent ratings showing a mix of bullish and somewhat bullish sentiments. The average 12-month price target has decreased slightly to $26.25. Despite challenges in revenue growth, the company shows strong financial health with high net margins and ROE. However, its high debt-to-equity ratio indicates financial risk.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:01 pm

ORCL

The article provides an in-depth analysis of Oracle (NYSE:ORCL) in comparison to its competitors in the software industry. It highlights Oracle's financial metrics, market positioning, and growth potential, indicating potential undervaluation based on P/E and P/S ratios, but overvaluation on P/B ratio. Oracle shows strong profitability with high EBITDA and gross profit, but faces challenges with lower revenue growth compared to industry peers.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm

DINO

HF Sinclair (NYSE:DINO) has been analyzed by 12 analysts, showing a range of ratings from bullish to bearish. The average 12-month price target is $56.92, a decrease from the previous $61.00. Analysts have adjusted their ratings and price targets, reflecting dynamic market conditions. HF Sinclair is an integrated petroleum refiner with strong financial metrics, including a high net margin and ROE.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm

COLB

Columbia Banking System (NASDAQ:COLB) has received 10 neutral ratings from analysts in the past three months, with an average 12-month price target of $26.2, up from $22.30. Analysts have adjusted their ratings and price targets, reflecting changing market conditions. Despite these updates, Columbia Banking System faces challenges with revenue decline, low net margin, and high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm

V

The article provides a comprehensive comparison of Visa (NYSE:V) with its competitors in the Financial Services industry, focusing on key financial metrics. Visa shows potential for growth with a lower P/E ratio than the industry average, but its high P/B and P/S ratios suggest it may be overvalued. Visa's ROE, EBITDA, and gross profit indicate strong profitability and operational efficiency, though its revenue growth lags behind the industry average.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm

ABCB

In the past three months, 5 analysts have rated Ameris Bancorp (NYSE:ABCB) with a mix of bullish and somewhat bullish sentiments. Analysts have set a 12-month average price target of $69.4, reflecting a 17.23% increase from the previous target. Recent analyst actions include raised ratings and price targets, indicating positive sentiment towards Ameris's financial performance, which includes strong revenue growth, net margin, and efficient debt management.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm

CACI

CACI International (NYSE:CACI) has significantly outperformed the market over the past 15 years, with an average annual return of 16.71%. A $100 investment in CACI 15 years ago would now be worth $1,039.18, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm

DELL

Dell Technologies (NYSE:DELL) has significantly outperformed the market over the past 5 years, with an annualized return of 34.53%. A $1000 investment in DELL 5 years ago would now be worth $4,345.25. This highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm

LLY

Eli Lilly (NYSE:LLY) is analyzed against its competitors in the Pharmaceuticals industry. The company shows high valuation metrics (PE, PB, PS ratios) compared to industry averages, suggesting potential overvaluation. However, its high ROE and revenue growth indicate strong performance. Concerns arise from lower EBITDA and gross profit levels, which may affect operational efficiency and profitability.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 3:00 pm